ArticleParasites & vectors2025
Assessing the vector competence of Italian Culex pipiens and Aedes albopictus mosquitoes for the re-emerging Oropouche virus.
Article in Parasites & vectors, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Low Generation Culex quinquefasciatus from Texas and Culex pipiens from New Jersey Are Incompetent Vectors for Oropouche Virus.The American journal of tropical medicine and hygiene · 2026Article
- Pediatric Arboviral Infections in Europe: Epidemiology, Clinical Features, Diagnosis and Prevention.Viruses · 2026Review
- Oropouche virus causes acute hepatitis in mice controlled by type I interferons.Journal of virology · 2026Article
- Are mosquito species present in Spain competent for Oropouche virus?Parasites & vectors · 2026Article
- Oropouche virus: transmission, epidemiology, genetic diversity, and public health implications.EClinicalMedicine · 2026Review
- Oropouche virus causes acute hepatitis in mice controlled by Type I interferons.bioRxiv : the preprint server for biology · 2026Article
- What are the vector species of the Oropouche virus?Pest management science · 2026Review
- Low risk of transmission of prototype and newly emerged Oropouche virus strains by European Culex pipiens, Aedes albopictus, and Anopheles atroparvus mosquitoes.PLoS neglected tropical diseases · 2026Article
- Sustained Oropouche virus transmission in Rio de Janeiro's Atlantic Forest: genomic evidence over a two-year period.Memorias do Instituto Oswaldo Cruz · 2026Article
- Oropouche Virus: An Emerging Arboviral Threat and Its Implications for Europe.Life (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIn 2024, Italy reported its first five cases of Oropouche fever in travelers returning from Cuba and Brazil. The Oropouche virus (OROV), an emerging Orthobunyavirus of the Peribunyaviridae family, is a zoonotic arbovirus responsible for febrile illnesses in humans, often misdiagnosed owing to its clinical similarity to those caused by dengue and Zika virus infections. Originally endemic to the Amazon region and first detected in Trinidad and Tobago in 1955, OROV has since spread throughout South and Central America. Recent outbreaks in Brazil and Cuba have been linked to the newly identified genotype V. Although Culicoides paraensis midges are recognized as the primary vector in the urban transmission cycle, their presence in Cuba was documented only after the outbreak. This late detection, coupled with a possibly low population density of this species, has raised concerns that other, more abundant arthropod species may have played a role in transmitting OROV to humans on the island. While some mosquito species have been implicated as potential OROV secondary vectors, their role remains uncertain. This study evaluates the vector competence of Italian populations of Aedes albopictus and Culex pipiens for the newly circulating OROV strain, which was introduced into the country by infected travelers.
methodsExperimental infections were conducted under biosafety level 3 conditions, exposing adult female mosquitoes to an infectious blood meal containing OROV. Viral presence was assessed using a real-time RT-PCR in mosquito bodies, legs + wings, saliva, and the first gonotrophic progeny (F1).
resultsResults indicated that, while both species successfully ingested infectious virus particles, Cx. pipiens exhibited no signs of infection, dissemination, or transmission at any time point. In Ae. albopictus, viral RNA was detected in two body samples but not in saliva or disseminated tissues, confirming an absence of transmission capability. In addition, no evidence of transmission to F1 generation was detected in either species. These findings are consistent with previous research on American mosquito populations, indicating that barriers to OROV transmission likely occur at the midgut level.
conclusionsDespite the apparent lack of vector competence in Italian Ae. albopictus and Cx. pipiens, the ongoing geographic expansion of OROV highlights the need for continued surveillance, particularly as the 2025 vector activity season approaches in Europe. The increasing circulation of the virus, along with its potential for adaptive evolution, highlights the importance of further research into the virus-vector interactions that could enable OROV to establish itself in new ecological niches.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.